Clinical Trials
296
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (186 trials with phase data)• Click on a phase to view related trials
Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation
- Conditions
- AML - Acute Myeloid LeukemiaMDS (Myelodysplastic Syndrome)
- Interventions
- Drug: Treosulfan (Treo)Drug: Melphalan (Mel)Drug: Fludarabine (Flud)
- First Posted Date
- 2025-06-18
- Last Posted Date
- 2025-06-22
- Lead Sponsor
- Technische Universität Dresden
- Target Recruit Count
- 220
- Registration Number
- NCT07025824
- Locations
- 🇩🇪
Medizinische Fakultät der TU Dresden, Medizinische Klinik und Poliklinik I, Dresden, Germany
🇩🇪Universitätsmedizin Halle (Saale), Halle (Saale), Germany
🇩🇪Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany
Radiation-induced Toxicity of the Heart
- Conditions
- Non-small Cell Lung CancerEsophageal CancerBreast Cancer Female
- First Posted Date
- 2025-05-23
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- Technische Universität Dresden
- Target Recruit Count
- 325
- Registration Number
- NCT06986291
- Locations
- 🇩🇪
University of Technology, University Hospital Carl Gustav Carus, Department of Radiation Therapy and Radiation Oncology, Dresden, Germany
Replication of the Heads Up Atopic Dermatitis Trial With Registry Data
- Conditions
- Atopic Dermatitis
- Interventions
- First Posted Date
- 2025-04-22
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- Technische Universität Dresden
- Target Recruit Count
- 240
- Registration Number
- NCT06937788
- Locations
- 🇩🇪
Center for Evidence Based Health Care, Dresden, Saxony, Germany
The Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease.
- Conditions
- Melanoma of Skin
- First Posted Date
- 2025-01-09
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Technische Universität Dresden
- Target Recruit Count
- 3000
- Registration Number
- NCT06765850
- Locations
- 🇩🇪
University Hospital Carl Gustav Carus, Dresden, Saxony, Germany
Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Neoplasia With IDH1 (Isocitrate Dehydrogenase 1) Mutation
- First Posted Date
- 2024-12-05
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- Technische Universität Dresden
- Target Recruit Count
- 76
- Registration Number
- NCT06717958
- Locations
- 🇩🇪
Universitätsklinikum Aachen, Aachen, Germany
🇩🇪Technische Universitaet Dresden, Medizinische Klinik und Poliklinik I, Dresden, Germany
🇩🇪Universitätsklinikum Essen, Essen, Germany
- Prev
- 1
- 2
- 3
- 4
- 5
- 49
- Next